SCHEMBL23092309

SCHEMBL23092309

CC(C)(C)OC(=O)N1CCN(c2ncnc3c(F)c(-c4c(F)cccc4OCCCCCCC=O)c(Cl)cc23)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 9/20 0.54
▸ EGFR P00533 1/20 0.54
▸ HMOX2 P30519 1/20 0.54
▸ CRYZ Q08257 1/20 0.54
▸ VAT1 Q99536 1/20 0.54
▸ RTN4 Q9NQC3 1/20 0.54
▸ KIT P10721 2/20 0.41
▸ CXCR2 P25025 1/20 0.39
▸ CNR1 P21554 1/20 0.39
▸ CNR2 P34972 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.36
▸ GALR2 O43603 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ GPR119 Q8TDV5 3/20 0.35
▸ EPHA2 P29317 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ EPHB4 P54760 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23092322 0.90 KRAS (0.58) KRASEGFRHMOX2CRYZVAT1
SCHEMBL23092614 0.89 KRAS (0.56) KRASEGFRHMOX2CRYZVAT1
SCHEMBL16637040 0.87 KRAS (0.59) KRASEGFRHMOX2CRYZVAT1
SCHEMBL23092376 0.87 KRAS (0.50) KRASEGFRHMOX2CRYZVAT1
SCHEMBL30167396 0.83 KRAS (0.62) KRASEGFRHMOX2CRYZVAT1
SCHEMBL23105086 0.82 KRAS (0.54) KRASEGFRHMOX2CRYZVAT1
SCHEMBL23105132 0.82 KRAS (0.70) KRASEGFRHMOX2CRYZVAT1
SCHEMBL30167488 0.81 KRAS (0.63) KRASEGFRHMOX2CRYZVAT1
SCHEMBL23105141 0.81 KRAS (0.69) KRASEGFRHMOX2CRYZVAT1
SCHEMBL23415350 0.80 KRAS (0.56) KRASEGFRHMOX2CRYZVAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021051034-A1 RAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2021-03-18 — — WO disclosed
Send feedback